Last update:

Urology news

Team targets the spinal cord to solve paralysis' most overlooked problem

Approximately 308,000 people in the United States live with spinal cord injury. Nearly all lose bladder control. And yet the vast majority of research and engineering attention in neurotech has poured into motor restoration—making ...

Tumor bacteria inspire peptide that starves prostate cancer cells in preclinical tests

Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. When tested in combination with radiation in animal models of prostate cancer, it was highly ...

Erectile disorder: How science is moving beyond Viagra

Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond ...

Can the pill be side-effect free and taken on demand?

Preventing pregnancy is largely viewed as the responsibility of anyone who can become pregnant. It's a burden that can hold significant emotional, financial and physical weight (not just the bathroom scale kind).

A big step toward safe, reversible male contraception

Cornell scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A proof-of-principle study in ...

HRT patches to treat prostate cancer—here's how it works

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst side effects—according to a large UK trial published in the New England Journal of Medicine. The ...

FDA warns biotech firm over cancer drug claims

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

New guide aims to tame the chaos of UTI care

Millions of times a year, Americans seek urgent treatment for painful, embarrassing urinary tract infections. But while they once had to go in person for testing and treatment, now they can type messages to their clinic into ...

Predicting prostate cancer recurrence through power of AI

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's Department of Radiation Oncology developed the PSA ...

New model improves prediction of prostate cancer death risk

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models. The tool, tested on over ...

Radiotracers could improve choice of bladder cancer therapies

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that can visualize tumors that carry the cell surface protein Nectin-4. This primarily occurs in the body ...